“Psychotropic medications and children: science, Law, and Policy” UC Hastings college of law symposium on children’s health, mental health & the law March.

Slides:

Advertisements

Similar presentations

Mission: Protect the Vulnerable, Promote Strong and Economic Self-Sufficient Families, and Advance Personal and Family Recovery and Resiliency. Charlie.

Advertisements

What Every Educator in Volusia County Schools Needs to Know.

Michael W. Naylor, M.D. University of Illinois at Chicago Director, Clinical Services in Psychopharmacology.

IMPLEMENTING THE ACA: HOW MUCH WILL IT HELP VULNERABLE ADOLESCENTS AND YOUNG ADULTS? Abigail English, JD Center for Adolescent Health & the Law

Critical Issues for Successful Implementation.  Samanthya Amann, Iowa  Nicole Byers, Delaware  Kate Hanley, Consultant with the NRCYD.

Working Across Systems to Improve Outcomes for Young Children Sheryl Dicker, J.D. Assistant Professor of Pediatrics and Family and Social Medicine, Albert.

Quality Improvement Project (QIP)

BACKGROUND: ANTIPSYCHOTIC TREATMENT OF YOUNG CHILDREN.

California Department of Social Services Program Improvement Plan

1 Milwaukee County Child Welfare Legislative Audit Bureau September 2007.

Children’s Identity Management 46 th Annual IT Solutions Management for Human Services San Diego, CA October 5 th – 9 th, 2013.

QI Initiatives for Psychotropic Use in Foster Youth in Maine Lindsey Tweed MD MPH Office of Child & Family Services; Maine DHHS

Arkansas Children’s Behavioral Health Care Commission AR DHS Division of Medical Services Pharmacy Program Laurence H. Miller, M.D., Senior Psychiatrist.

1 Nina Jo Muse, MD, Psychiatric Advisor State Hospital Section, Mental Health Substance Abuse Division Texas Department of State Health Services Psychotropic.

1 Child Welfare Reform Council August 5, 2014 Transition of Children in Foster Care, Receiving Adoption Assistance and Select Youth in Juvenile Justice.

February 10, 2011 San Diego.  Federal law enacted in 2008  Intent to improve well-being and permanency outcomes for court dependent children  Two California.

Q UALITY I MPROVEMENT P ROJECT (QIP) “Improving the Use of Psychotropic Medication Among Children and Youth in Foster Care” Informational Presentation.

American Academy of Pediatrics and Children’s National Medical Center Joseph L. Wright, MD, MPH Professor of Pediatrics, Emergency Medicine & Health Policy.

Mission: Protect the Vulnerable, Promote Strong and Economically Self- Sufficient Families, and Advance Personal and Family Recovery and Resiliency. Charlie.

Consent for Psychotropic Medication

1 Subtitle SCHOOL-BASED MEDICAID. 2 New CMS Regulations Seven new regulations during the past 18 months, which threaten the health care safety net: 1.School-Based.

P.K. Leebens, 2012 Mental Health Consultation within State Child Agency Patricia K. Leebens, MD Clinical Assistant Professor Yale Child Study Center Former.

1 Child Welfare Improvement Overview House Appropriations Subcommittee Kathryne O’Grady, Deputy Director Michigan Department of Human Services September.

Thomas I. Mackie, MA, MPH Tufts Clinical and Translational Science Institute Tufts University Boston, MA.

Office of Children’s Mental Health WCHSA Conference May 14, 2015.

NW Minnesota Council of Collaborative’s: “Our Children Succeed Initiative” Overview 2/7/07.

CHIPRA Foster Care Initiative FYI – Comparison of Standards Esther Smith MD Pediatrician Triad Adult & Pediatric Medicine Guilford Child Health Guilford.

Montana Community Choice Partnership Money Follows the Person (MFP) Demonstration Grant Stakeholder Advisory Council Meeting March 10, 2015.

A Big Unknown : How to Use Data to Improve Policy and Quality Jeffery Thompson, M.D. Chief Medical Officer Washington State Medicaid Academy Health Washington.

1 Informed Consent and Monitoring of Psychotropic Medications in Texas Kathy Teutsch, RN, LMSW-MSSW: CPS Division Administrator for Medical Services SHARED.

11 Understanding and Improving the Quality of Psychotropic Management and Mental Health Services for Foster Youth: Metric-Driven State QI Strategies Stephen.

IMPROVING THE USE OF PSYCHOTROPIC MEDICATIONS IN CHILDREN AND YOUTH IN FOSTER CARE Oregon CHCS team Advisory Committee June 15, 2013.

1 CAPTA Provision on Referrals to IDEA Part C National Early Childhood Conference December 12, 2005 Catherine M. Nolan.

Psychoactive drugs and New Child Psychiatric services for Wyoming James Bush MD, FACP Medicaid Medical Director Wyoming Dept of Health August 27-28,2012.

PARTNERSHIP TO IMPROVE DEMENTIA CARE THE OHIO APPROACH.

A National Assessment of Youth Involved with Child Welfare: Prevalence of Emotional and Behavioral Problems, Access to Treatment, and the Role of Court.

Joint Finance Committee Hearing FY 2012 Susan Del Pesco Division Director Wednesday, March 2, 2011 Division of Long Term Care Residents Protection.

Judge Mark Pouley Commissioner Michelle Ressa October 9, 2012 ICW Summit.

1 Anti-psychotic Medication in Children, Adolescents and Foster Care: Too Many, too Much, and too Young Medicaid Medical Directors Learning Network (MMDLN)

“Reaching across Arizona to provide comprehensive quality health care for those in need” Our first care is your health care Arizona Health Care Cost Containment.

National Academy for State Health Policy © State Options for Covering Young Adults State Coverage Initiatives Workshop for State Officials August.

Coping with Mental Illness and Crafting Public Policy Coping with Mental Illness and Crafting Public Policy January 12, 2002 Being There: Making a Commitment.

The Power of the Rare Disease Community… Diane Dorman Vice President, Public Policy National Organization for Rare Disorders (NORD) 1 st International.

OVERVIEW OF STATE APPROACHES TO OVERSIGHT AND MONITORING OF PSYCHOTROPIC MEDICATIONS Joyce Pfennig, Ph.D. Kate Stepleton, MSW.

1. 2  Many of the children I advocated for were taking some sort of psychotropic medication  Many of them were on multiple psychotropics  Many of them.

March 2, 2011 Status of the Patent Budget. 2 Steps in the Budget Process Strategic Planning – long term Budget Formulation and Performance Planning -

Data Integration Efforts and Challenges Scott M. Bilder, Ph.D. Institute for Health, Health Care Policy, and Aging Research Rutgers, The State University.

Joint Finance Committee Hearing FY 2013 Susan Del Pesco Division Director February 21, 2012 Department of Health and Social Services Division of Long Term.

M eaningful Quality Measures for Children with Behavioral Health Conditions Discussion with the NYS Conference of Local Mental Health Hygiene Directors.

Racial/Ethnic Differences in Pediatric Antipsychotic Use by FDA Labeled/Off-label Status MARYLAND CENTER FOR EXCELLENCE IN REGULATORY SCIENCE & INNOVATION.

1 Milwaukee County Child Welfare Legislative Audit Bureau March 2007.

1 CHILDREN SAFE AND THRIVING WITH FOREVER FAMILIES, SOONER DIVISION OF FAMILY & CHILDREN SERVICES Isabel Blanco, Deputy Director of Field Operations September.

11/28/12 1 CALIFORNIA FOSTERING CONNECTIONS TO SUCCESS ACT Version 2.0 Assembly Bill 12.

1. Lori Fuller, Bureau Chief CFSD Fernando Sandoval, Manager II CCLD 2.

California State University Monterey Bay

ESSB 6656 Overview and Scope of the Select Committee on Quality Improvement in State Hospitals April 29, 2016 Kevin Black, Senate Committee Services Andy.

Health Care Reform IT’S COMPLEX! Jeffery Thompson, MD MPH Chief Medical Officer Washington State Medicaid.

Closing the Gap for Skipped- Generation Households.

© NCYL 0 Addressing the Over- Medication of Foster Youth What can we learn from state initiatives? March 15, 2016 Nathan Kamps-Hughes, Policy Researcher.

Delaware's children in foster care – health service utilization May 4, 2016 Presented by: Catherine Zorc, MD, MPH, Nemours Katie Gifford, MS, Center for.

The Children’s Aid Society of Brant Preliminary Findings Crown Ward Review 2011 February 28-March 10, 2011.

Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.

Copyright © 2017 American Academy of Pediatrics.

The Future of CCS: SB 586 and Protections for Children and Families

Fostering Connections to Success and Increasing Adoptions Act: New Opportunities for Federal Funding for Child Welfare Key Questions and Considerations.

Disability diagnosis & Primary Care Management

Psychotropic Medication Use by Children in Texas Foster Care:

Pediatric Therapeutics Still working to get it right for kids

Foster Care to 21 Carl E. Ayers, MSW

Presentation transcript:

“Psychotropic medications and children: science, Law, and Policy” UC Hastings college of law symposium on children’s health, mental health & the law March 29, /29/14Bill Grimm1

Federal Focus & ActionCourt Resolution & The JV220 ProcessState InitiativesPsychotropic Drug ConcernsStandard of CarePrioritizing Policies & ActionsImproving Prescribing Practices 3/29/14Bill Grimm2

Federal Focus and Action February 2006: Senate Finance Committee Testimony October 2008: Federal Fostering Connections to Success and Increasing Adoptions Act September 2011: Child and Family Services Improvement and Innovation Act November 2011: Joint Letter from ACF, CMS, SAMHSA, HHS December 2011: GAO Report Foster Children April 2012: Children’s Bureau Information Memorandum August 2012: ACF Because Minds Matter Conference December 2012: GAO Report Children’s Mental Health August 2013: HHS Office of the Inspector General Investigation March 2013: The President’s Budget - $750 million 3/29/14Bill Grimm3

Federal Focus and Action “I think putting me on all these stupid meds was the most idiotic thing I have ever experienced in foster care and was the worst thing someone could do to foster kids. I was upset about my situation, not bipolar or ADHD.” Testimony of Ke’onte Cooke, 12 year old former foster child, before Congress, December 1, /29/14 Bill Grimm 4

Court Resolution & The JV220 Process National Council of Juvenile & Family Court Judges Resolution Whereas, Judges in child welfare and juvenile justice cases are responsible for overseeing the safety and well-being of children under court jurisdiction; Whereas, the NCJFCJ believes that this oversight responsibility extends to children prescribed psychotropic medications, including ensuring that medications are safe and appropriate… 3/29/14Bill Grimm5

Court Resolution & The JV220 Process JV-220 Process Statute enacted in 1999 Intended to reduce use of psychotropic drugs Is the Court Review & Authorization Process effective? 3/29/14 Bill Grimm 6

3/29/14Bill Grimm7 COURT RESOLUTION & THE JV220 PROCESS

Percentage of Children Authorized Psychotropic Medications By Placement Type Apr-Jun /29/14Bill Grimm8 COURT RESOLUTION & THE JV220 PROCESS

3/29/14Bill Grimm9

State Initiatives September 2010: AB 12 Passed August 2012: Because Minds Matter Conference October 2012: Quality Improvement Project Charter Kick-off January 2012: “Monthly” Workgroup Calls Clinical Workgroup Data and Technology Workgroup Youth, Family and Education Workgroup August 2013: Draft Action Plan Circulated September 2013-February 2014: State Process Suspended February 26 th, 2014: Invitation Only Meeting March 26 th, 2014: Meeting to Kick-off Workgroups 10/21/13Anna Johnson10

Psychotropic Drug Concerns Too Many Too Much Too Soon Too Long No Monitoring (Mis- Over- Inaccurate) Diagnoses No Risk/Benefit Profiles Untested Off-label No Alternatives Adverse Effects Powerful Opposition Untrained Caregivers Lack of educational resources 3/29/14Bill Grimm11

Too Many Children in care medicated Children on multiple medications Inaccurate diagnoses 3/29/14Bill Grimm12 ABC News Investigation Psychotropic Drug Concerns

Too Much Above maximum dosages Adult dosages for children 3/29/14Bill Grimm13 Gabriel Myers Story Psychotropic Drug Concerns

Too Soon Very young ages Too early in placement Before other interventions 3/29/14Bill Grimm14 Tiffany's Story Psychotropic Drug Concerns

Too Long No set monitoring No timeline to taper off Authorization for indefinite amount of time 3/29/14Bill Grimm15 Tristen's Story Psychotropic Drug Concerns

Standard of Care Policy Sources: Appropriate Use of Psychotropics  American Academy of Child & Adolescent Psychiatry (AACAP)  Child Welfare League of America (CWLA)  HEDIS  American Academy of Pediatrics (AAP)  State Legislation  Medicaid Medical Directors Learning Network (MMDLN) 3/29/14Bill Grimm16

Prioritizing Policies & Actions Special Populations  Very young children  Child-bearing age youth  Youth transitioning from care  Group home youth 3/29/14Bill Grimm17

3/29/14Bill Grimm18 Prioritizing Policies & Actions Antipsychotics  Limited FDA approval  Off-label prescription  Adverse Effects  Disruptive Behavior Diagnoses

3/29/14Bill Grimm19 Maximum Dosing  LA Parameters  Connecticut Guidelines Prioritizing Policies & Actions

3/29/14Bill Grimm20 Prioritizing Policies & Actions Polypharmacy

3/29/14Bill Grimm21 Prioritizing Policies & Actions Gaps in Medications

Improving Prescribing Practices Consultation & Second Review  California  Child Psychiatrists  Public Health Nurses  Pharmacists  Minnesota  Washington 3/29/14Bill Grimm22

Improving Prescribing Practices Prior Authorizations/TARS  CA 2006 TAR for antipsychotic prescriptions for children under six  Prescriptions fell from 5686 to /29/14Bill Grimm23

Improving Prescribing Practices Monitoring Requirements & Baseline Metabolic Testing  AK requires baseline lab testing and 9 month follow ups  NJ has a detailed monitoring protocol by drug class 3/29/14Bill Grimm24

Improving Prescribing Practices Outlying Prescriber Identification  Many states use Medicaid pharmaceutical data to identify inappropriate prescribing patterns 3/29/14Bill Grimm25

Improving Prescribing Practices Academic Detailing  Prescriber education and outreach  Safe Rx Amendment Act of 2008 established an academic detailing program in Washington, D.C. 3/29/14Bill Grimm26

Discussion and Questions 3/29/14Bill Grimm27